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Abstract
Background: The objective of this study was to identify important attributes associated with the triad of symptoms (cognition, emotional–behavioral, and motor)
of Huntington’s disease (HD) from patient, caregiver, and medical provider perspectives to facilitate development of a new disease-specific, health-related quality of
life (HRQOL) instrument.
Methods: We conducted a targeted literature review of HD and HRQOL instruments, expert surveys, and patient and caregiver phone-based interviews to extract
information on the symptoms and issues most relevant to the HD symptom triad (HD triad). The data collected from these sources were used to generate themes
and subdomains and to develop an integrated schema that highlights the key dimensions of the triad.
Results: The search identified the following areas: emotional functioning/behavioral changes (e.g., positive emotions, sadness/depression); cognitive functioning
(e.g., memory/learning, attention/comprehension); physical functioning (e.g., motor functioning, medication); social functioning (e.g., leisure, interpersonal
relationships); end-of-life concerns/planning; and gene testing. Fifteen individuals diagnosed with HD and 16 HD caregivers, recruited from several Huntington’s
Disease Society of America support group networks, completed phone interviews. Nineteen US medical providers who specialize in HD completed the online
survey. Twenty-six subdomains of the HD symptom triad (seven cognition, 12 emotional–behavioral, and seven motor) emerged relatively consistently across
patient, caregiver, and provider samples. These included movements/chorea, memory impairment, depression, and anxiety.
Discussion: Based on an integrated, mixed-methods approach, important HD triad symptom were identified and organized into a guiding schema. These patient-,
caregiver-, and provider-triangulated data served as the basis for development of a HD-specific HRQOL instrument, the HD-PRO-TRIADTM.
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Introduction
Huntington’s disease (HD) is a rare, autosomal dominant,
neurologic disorder that affects approximately three in 100,000
individuals worldwide.1 HD is caused by a CAG trinucleotide repeat
expansion in the gene encoding the huntingtin protein on the short
side of chromosome 4, with affected individuals having at least one
allele with 36 or more repeats.2 HD symptoms typically begin subtly
and gradually worsen, generally leading to a clinical diagnosis of HD
Freely available online
Tremor and Other Hyperkinetic Movements
http://www.tremorjournal.org
The Center for Digital Research and Scholarship
Columbia University Libraries/Information Services1
near the age of 40 years, though age of symptom onset is associated
with the number of expansions in the longest HD allele.3 Death usually
occurs approximately 20 years after initial diagnosis.4
HD is characterized by a triad of insidious and progressive
cognitive, emotional–behavioral, and motor symptoms5 (hereafter
referred to as the ‘‘HD triad’’). The symptom presentation for any
given individual can include one or all of the HD triad domains.
Cognitive symptoms can include forgetfulness, attention difficulties,
executive dysfunction, and, at the later stages, dementia.6–9
Emotional–behavioral symptoms may include apathy, depression,
aggression, disinhibition, anxiety, and perseverative behaviors.9,10
Motor symptoms generally include chorea, bradykinesia, ataxia, and
dystonia.9 In addition to the difficulties associated with the symptoms
themselves, the HD triad can have a negative impact on family
functioning, other social relationships, and the ability of the patient to
work. As a result, HD has a substantial deleterious effect on health-
related quality of life (HRQOL).11–13
Recent studies have examined the broader impact of HD on global
areas of HRQOL, such as emotional, physical, cognitive, and social
health.13–15 Carlozzi et al.13 conducted a series of focus groups with
individuals at risk for and with prodromal or symptomatic HD, as well
as caregivers and clinical providers for patients with HD, to identify
the most important aspects of HD-specific HRQOL. Overall, they
reported that emotional, social, and physical areas were discussed
relatively evenly across groups (between 26% and 28%), while
cognitive health and end-of-life issues were discussed less frequently
(9–10%).13
Two HD-specific HRQOL instruments were recently published.
The first was based on semi-structured interviews with individuals with
pre-symptomatic through late stage HD.15 Findings from these
interviews were used to develop the Huntington’s Disease Quality of
Life questionnaire, a new measure of global HRQOL in HD that
focuses on cognitive, emotional, physical, and functional aspects of
HD. The second emerged from a European study that employed
French and Italian self-reported questionnaires to develop a
Huntington Quality of Life Instrument (H-QoL-I) composed of three
domains: motor, psychology, and socializing.16
While aspects of the HD triad were explored during development of
the two existing HRQOL measures, neither study spanned the HD
triad and specifically focused on their direct implications. In other
words, they did not fully cover the full HD triad of cognitive,
emotional–behavioral, and motor symptoms. The study presented
here collected findings from an expert survey and semi-structured
patient and caregiver interviews designed to explore the HD symptom
triad (HD triad), its impact, and how it may inform new outcome
measurement tools. These data were used to design a HD-specific
patient-rated outcome (PRO) scale (HD-PRO-TRIADTM) to assess the
impacts of the HD triad on HRQOL.17
Methods
A grounded theory qualitative research approach was used to gather
data on patient, caregiver, and medical provider experiences with HD
triad symptomatology and derive a conceptual understanding of the
grounded views of those affected by the HD triad.18 Consistent with
this approach, several stages of data collection and modification were
employed, each characterized by constant comparison of data with
emergent themes and purposive sampling of different perspectives.
This included a targeted literature review, expert surveys, and
individual phone-based interviews with HD patients and their
caregivers. The study was approved by the Northwestern University
Institutional Review Board.
Targeted literature review
A literature search via PubMed/MEDLINE was conducted to
identify important HRQOL domains commonly associated with the
HD triad. The search identified the following areas: emotional
functioning/behavioral changes (positive emotions, sadness/depres-
sion, anxiety/fear, anger, self-esteem, and behavioral changes);
cognitive functioning (memory/learning, attention/comprehension,
executive functioning, and orientation); physical functioning (motor
functioning, medication, fatigue, vision changes, sexual functioning,
and health promotion); social functioning (leisure, interpersonal
relationships, and vocation); end-of-life concerns/planning; and gene
testing. These domains were subsequently used as the basis for the
development of individual interview guides with patients and
caregivers, and expert surveys.
Expert surveys
An online survey for HD medical providers and key opinion leaders
was developed after the extensive targeted literature review of
HRQOL issues associated with HD and current measures that assess
HD-related HRQOL. The survey was hosted online and sought to
obtain insights regarding the HD triad of symptoms and their impacts
on HRQOL. Experts were asked to free-list cognitive, emotional–
behavioral, and motor symptoms issues or concerns that patients with
HD experience, and rate their importance and prevalence based on a
4-point Likert scale (15not at all common/important to 45extremely
common/important). Similarly, they were also asked to rate the
prevalence and relevance of a list of pre-generated HD triad issues
based on the literature review. All data were entered into a relational
database and summarized into themes by three study team members
(N.C., C.N., A.M.) with qualitative data analysis experience.
Patient and caregiver individual phone-based interviews
Individual telephone-based interviews were conducted to explore
the most important issues related to the HD triad, including global life
changes, symptoms, adverse effects, and ways of coping. Patients and
caregivers were invited to participate through HD Lighthouse and
Huntington’s Disease Society of America (HDSA) support groups
representing California, Texas, New York, Florida, and Illinois. These
regions were chosen to ensure a broad US geographic sample
distribution and because they offered relatively greater numbers of
support groups. Patients were eligible to participate if they met the
following inclusion criteria: a) diagnosed with HD; b)>18 years of age;
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c) able to actively participate in an individual phone-based interview;
and (d) able to read, write, speak, and understand English. Caregivers
were eligible if they self-identified as a caregiver for someone
diagnosed with HD. (However, not all caregivers were actively caring
for someone with HD. In a few instances, caregivers had cared for
family members with HD who had died before the interviews.)
General exclusion criteria included: a) physical debilitation such that
study participation in an individual interview would not be feasible or
would create undue hardship; and b) history of diagnosed severe
mental illness or hospitalization for chronic psychiatric reasons.
Interested patients and caregivers provided consent and were called
by trained research coordinators to schedule a recorded telephone
interview. One week prior to the individual interviews, the research
coordinators telephoned participants to remind them of the dates and
times. Participants mailed signed consent forms via prepaid return
postage sent by the research coordinators prior to the interviews.
As part of the registration process, all participants were asked to
complete a demographics form (returned via post with the consent
form). This information was summarized to provide a description of
sample participant demographics. By tracking participant character-
istics throughout the registration process, we modified recruitment as
needed to include patients with under-represented attributes, ensuring
a sample that accurately reflected the general HD patient population.
Interviews were conducted by trained research team members who
followed a semi-structured moderator’s guide, which had been
developed from guides used in similar previously conducted NIH-
funded studies.19 At the conclusion of the individual interviews,
participants received a $35 incentive in the form of a gift card. All
individual interviews were audio-recorded, and notes taken by the
moderator were also recorded within 60 minutes. Digital recordings of
the interviews were transcribed verbatim via a professional transcrip-
tion service. All identifying patient information was excluded from
these transcripts.
Analysis
Expert survey and interview response transcriptions and moderator
notes were read and examined systematically by at least two study
team members (DV, NC) to obtain a general impression of the data,
which, supplemented with current literature, allowed two additional
raters (C.N., A.M.) to independently generate a mutually agreed upon
list of themes and dimensions of major ideas. Through multiple raters,
variance was reduced, lending a greater degree of credibility to the
analysis. Through open and selective coding approaches and constant
comparative methods, an iterative coding process was employed to
create coding definitions and rules and, thus, identify and organize
common themes. Comments were organized into codes and larger
themes, and frequency tables were created to reflect the number of
times a given code was applied compared with the rest of the codes.
The point of reaching data saturation was noted as patient records
were sequentially evaluated. Inter-rater reliability was assessed
following the development of the initial code book.
Based on analysis of themes identified from the expert surveys and
individual phone-based interviews, preliminary HD-PRO-TRIADTM
items were selected and compiled from relevant existing neurology-
related HRQOL item banks with content appropriate for the three
domains of the HD-PRO-TRIADTM instrument. To this end,
cognitive functioning items were selected from the Neuro-QOL
Cognition item banks20 and Traumatic Brain Injury-QOL
Cognition.21,22 Emotional/behavioral functioning items were selected
from the Neuro-QOL Emotional and Behavioral Dyscontrol item
bank, and motor functioning items were selected from the
HDQLIFETM chorea items23 and FACIT motor items.24
Results
Expert characteristics
Nineteen medical providers participated in the online survey, all of
whom reported being HD specialists. Seventeen providers (90%) were
doctors of medicine, one was a registered nurse, and one was a doctor
of osteopathic medicine. The majority of medical providers reported
having a specialty in movement disorders and treating more than 100
HD patients per year (Table 1).
Free-listed HD triad symptoms and issues
Free-listed HD triad symptoms and issues were categorized into three
domains—Cognition, Emotional–Behavioral Dyscontrol, and Motor.
The most frequently listed Cognition domain symptoms were executive
functioning, memory, and concentration (Table 2). The most frequently
listed Emotional–Behavioral Dyscontrol domain symptoms were anger,
depression, and anxiety. The most frequently listed Motor domain
deficits were movements (including chorea), balance, and incoordination.
Table 1. Expert Medical Provider Characteristics (n519)
Specialty in movement disorders 84.2%
Years of practice in HD, mean
(range)
19.5 (5–35)
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Table 2. Expert-Identified HD Triad Symptoms








Executive function 21.7% 3.64 3.00
Memory 21.7% 2.80 2.73
Concentration 14.5% 2.70 2.50
Attention 8.7% 3.33 3.00
Learning 5.8% 3.50 2.75
Perseveration 5.8% 3.00 2.50
Decision-making 4.4% 3.33 2.67
Insight/Awareness 4.4% 3.33 2.33
Judgment 4.4% 3.00 2.33
Adaptability 1.4% 2.00 2.00
Communication 1.4% 3.00 2.00
Job performance 1.4% 3.00 3.00
Mental fatigue 1.4% 2.00 3.00
Cognitive-related motor tasks 1.4% 3.00 3.00
Slowness/Processing speed 1.4% 2.00 1.00
Emotional/Behavioral Dyscontrol symptoms
Anger 22.1% 2.73 2.68
Depression 16.8% 3.19 2.88
Anxiety 13.7% 2.69 3.00
Apathy 8.7% 3.00 2.13
Obsessions/Compulsions 7.4% 3.00 2.86
Impulsivity 6.5% 3.00 2.67
Aggression 4.2% 2.50 3.50
Psychosis 4.2% 2.50 3.25
Poor coping 2.2% 3.50 3.00
Behavioral problems 1.0% 4.00 4.00
Personality change 1.0% 3.00 2.00
Sleep problems 1.0% 4.00 3.00
Stigma 1.0% 4.00 4.00
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Patient and caregiver characteristics
Fifteen patients and 16 caregivers were enrolled in this study. Data
from patient and caregiver interviews reflect nine independent samples
of patients, 10 independent samples of caregivers, and six paired
dyads. Mean age was 54 years for patients and 63 years for caregivers
(Table 3). The majority of patients and caregivers interviewed were
white, married, and female. Mean patient CAG trinucleotide repeat
lengths reported by patients and caregivers were similar. The reported
length of time with symptomatic HD was greater in caregiver reports
than in patient reports (mean was 120 months based on caregiver
reports vs. 92 months from patient reports), as was the percentage of
patients with late-stage HD (47% caregivers vs. 15% patients).
Patient and caregiver comments
Patients and caregivers were asked broad questions about how HD
had affected their lives in general, and also about any specific
experiences related to cognitive, emotional–behavioral, and motor
symptoms. During the coding process, global, unspecified comments
about HD triad constructs were encountered, such as, ‘‘I couldn’t do the
mental work’’ (in reference to cognition effects); ‘‘It [HD] tests your
emotional skills and asks you questions about your emotional stability
and all that’’ (in reference to emotional–behavioral effects); and ‘‘Motor
skills in a lot of different things that I do are affected’’ (in reference to
motor effects). Of the three domains (Cognition, Emotional–Behavioral
Dyscontrol, and Motor), motor issues were discussed most frequently by
patients and caregivers, followed by emotional–behavioral, and
cognitive issues. Table 4 presents the HD triad domains and their
subdomains, and the frequency with which each subdomain was
reported. For a more detailed view of the issues related to the HD triad
as reported by patients and caregivers, some typical passages from the
transcripts are provided in the following section.
Cognitive issues. For the Cognition domain, patients and caregivers
reported in similar degrees of frequency on attention/concentration
problems and HD triad awareness. Attention/concentration problems
were characterized by patients as difficulties doing simple calculations or
having sustained attention. One patient stated, ‘‘If I went to church or
Table 2. Continued








Movements 22.7% 2.88 2.59
Balance 13.5% 3.10 3.40
Incoordination 12.2% 3.00 2.78
Swallowing 9.5% 2.86 3.13
Mobility/Locomotion 8.1% 2.83 2.67
Speech 8.1% 3.17 2.67
Falls 6.8% 3.80 4.00
Rigidity 6.8% 3.00 3.20
Upper extremity/ADL 5.4% 2.75 3.25
Sleep 2.7% 2.00 3.00
IADL 1.4% 3.00 4.00
Pain 1.4% 2.00 2.00
Socialization 1.4% 2.00 2.00
Time extension 1.4% 3.00 4.00
14-point Likert scale: 15not at all common/important; 25somewhat common/important; 35very common/important; 45extremely common/important.
ADL: Activities of daily Living (e.g., bathing, dressing, eating); HD: Huntington’s disease; IADL: Instrumental activities of daily living (e.g., shopping, cooking, driving,
finances).
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went to anything, I couldn’t concentrate because I had all these different
things going through my head.’’ One caregiver described her experiences
with attention-related problems in a patient for whom she cared, ‘‘The
first thing that was probably noticeable was that he was not able to count
money or make change, and that’s been for years now. Just trying to
watch him count his change — well, he didn’t count his change. I’m like,
‘Don’t you ever check your change?’ And he would say ‘No,’ but upon
further questioning, I would find out that he really could not count it.’’
Table 3. Patient Characteristics as Reported by Patients and Caregivers
Patient Characteristics By Patients (n515) By Caregivers (n516)










CAG repeat length, mean (SD) 42 (3.1) 45 (3.9)
Patient had gene testing 92.9% 68.8%
Length of HD symptoms, mean (SD), months 92.1 (88.6) 120.1 (76.6)
Self-rated HD stage
Early HD 61.5% 33.3%
Middle HD 23.1% 20.0%










Length of relationship with patient, mean (SD), months NA 383.4 (170.7)
Length of role as caregiver, mean (SD), months NA 131.1 (128.3)
HD: Huntington’s disease; NA: Not applicable; SD: Standard deviation.
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Table 4. Patient- and Caregiver-reported HD Triad Symptoms and Issues, by Domains and Subdomains




Executive functioning 9.6% 15.9%
Attention/concentration 11.2% 12.5%








Aggression/behavioral dyscontrol 3.9% 3.1%















1Only HD triad-specific codes are listed here; 1145 total codes were applied to patients and 1,000 total codes were applied to caregivers.
2Frequency listed is the frequency at which each subdomain code was applied within its respective HD triad domain.
ADL: Activities of daily living; HD: Huntington’s disease.
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For HD triad awareness, both patients and caregivers reported that
overall patient awareness of deficits and cognitive decline was more or
less intact. One patient stated, ‘‘The second and third year, I started
noticing cognitive issues in myself,’’ while a caregiver reported, ‘‘He
knew what was going on around him. He knew who I was till the end.
He was aware of what was happening to him.’’
Patients and caregivers differed in their frequencies of discussing
other cognitive issues. For example, patients spent more time
discussing cognitive-related communication challenges, memory
problems, and slowed information processing, while caregivers spoke
more about executive functioning problems and perseveration (i.e.,
uncontrollable repetition of a meaningless word or phrase, or a
previously appropriate word or phrase that is no longer appropriate).
On memory worsening, one patient said, ‘‘I used to have all that in my
brain — everybody’s phone numbers, all the things I had to do for the
whole week and the month—and now it’s gone.’’ One caregiver
described her experiences with executive functioning problems, ‘‘He
cannot sequence things. If he was told orally to pick up a pencil, walk
over to the next office, sign a document, and bring the document and
the pencil back, he might pick up the pencil and not know what to do
next, or he might walk to the office and stand there and not know to
ask for the document. It’s a matter of sequencing things in their proper
order.’’ A patient also described her challenges with initiating tasks, ‘‘I
just put them off. My husband is great about this. If he’s got a doctor’s
appointment, he makes it, but I just put it off and put it off, where I
never used to do that.’’
Emotional–Behavioral Dyscontrol issues. Within the Emotional–
Behavior domain, patients and caregivers discussed several areas with
similar degrees of frequency, including aggression/behavioral dyscon-
trol, anger/irritability, anxiety, apathy, depression, emotional out-
bursts, and impulsivity. Anxiety and depression were discussed more
often.
For anxiety and depression, exemplary patient comments included
the following:
‘‘I ended up checking myself in to the hospital because I was
having suicidal thoughts and it was not good.’’
‘‘I think I cry probably three times a day or something. I mean it’s
just not normal the amount of times that I get sad. Things that make
me sad probably aren’t things that would make other people sad.’’
‘‘I worry about what’s going to happen, what’s really going to
happen and how long. I always say, ‘I’ve got 20 years,’ but that’s not
true. Ten, 15 years, and that makes me worry. That freaks me out.’’
‘‘The only thing that is like inside, like totally freaking me out, that
I’m really dreading, is when the chorea gets really bad, and I mean you
lose your — deformity. You know, your face, what it normally looks
like, you lose it. And your body’s all twisted up. That’s what really,
really, really bothers me out of the whole thing. From start to finish,
that’s the one thing I think about and I dread.’’
About anger, aggression, emotional outbursts and behavioral
dyscontrol, one patient stated, ‘‘I just started noticing a lot more
anger, aggression, just like lashing out of nowhere. If somebody did
something that would make you angry, you would get angry and walk
away. Well, I would break things or just lash out in different ways.’’ He
continued with the following admission, ‘‘I break stuff. I’ve broken
everything here. I’ve broken the dishwasher because I won’t listen to
instructions. I broke the stove because the things wouldn’t go back on
the right way, so I broke the stove.’’ In addition, patients alone
discussed obsessions/compulsions related to fixed schedules/routines,
resulting in difficulty adapting to change, or behaviors, such as
cleaning.
Caregivers spent more time discussing disinhibition, and only they
mentioned impatience, legal problems, and psychosis. One caregiver
stated, ‘‘He started where he was getting in trouble where he was
taking his clothes off and walking around the house without clothes on.
He started walking outside and the people in the neighborhood,
because we lived behind a school, people in the neighborhood who
had children would be calling the police. They would say that he’s
walking around without any clothes on. He was arrested for indecent
exposure.’’
Motor issues. Motor symptoms and issues were discussed by patients
and caregivers with similar frequency. The most frequently discussed
issue was chorea, followed by ambulation, and activities of daily living.
One patient described his chorea by stating, ‘‘My movement, my
chorea has increased. I have tremors.’’ Another patient described how
chorea interferes with her sleep, ‘‘I have torso movement all the time
that keeps me awake at night because they’re going 24 hours, you
know, something is moving all the time.’’
A caregiver described how chorea contributed to falls and
imbalance, ‘‘After about 10 years, he was falling a lot in the bathtub,
and he couldn’t stand up in the bathtub. He would be very, not
wanting help, but I would say once he fell out of the tub, you have to
get bath bench. I got things like that so that his quality of life would be
better so that he wasn’t falling and hurting himself. He fell down a
staircase twice in his life. That’s what the chorea movements did to
him.’’
In addition to movements and ambulation-related challenges,
several patients and caregivers discussed problems with speech and
swallowing. The following caregiver describes both issues, ‘‘After
awhile it got to where he couldn’t vocalize his thoughts. I would put
together a communication board where I had pictures of things like the
word ‘yes,’ the word ‘no,’ a toilet, a TV, and I would ask him ‘yes/no’
questions. Or ask him what do you want, what do you need? He could
point to stuff.’’ She continued by describing his challenges with
swallowing, ‘‘It was like he was eating one day, and then the next day,
he started having trouble where he was choking on stuff, and I started
having to pure´e things. It just got to where he just couldn’t get it to go
down even when it was pure´ed. It was like after awhile, it was all going
in to his lungs, and then, even after that, they told me he needed a
feeding tube, and then when he got the feeding tube, he seemed to gain
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Tremor and Other Hyperkinetic Movements
http://www.tremorjournal.org
The Center for Digital Research and Scholarship
Columbia University Libraries/Information Services8
weight back because he had lost so much weight because he wasn’t
getting the proper nutrition.’’
Inter-rater agreement and data saturation
Inter-rater agreement for patient and caregiver coding was greater
than 90% for all codes applied. In both patient and caregiver code
books, a total of 26 HD triad-specific codes were applied (Table 4), of
which one was applied only in the patient sample (obsession/
compulsion), and two codes were applied only in the caregiver sample
(legal problems and impatience). Data saturation (the point at which
no new codes were applied) was achieved after the third patient and
the third caregiver interviews. All subsequent interviews were analyzed
using code books developed from the first three interviews.
Integrating patient, caregiver and provider information
Overall, motor issues were most frequently discussed by patients,
caregivers, and medical providers, followed by emotional–behavioral,
and then cognitive issues. Of motor issues, chorea and related
movements were the most frequently described by patients, caregivers,
and medical providers. Anxiety and depression were the most
frequently described emotional–behavioral issues by patients and
caregivers, while anger was the most frequently listed symptom by
medical providers, followed by depression and anxiety. Of cognitive
issues, memory and perseveration were the most commonly discussed
by patients and caregivers, while executive functioning and memory
were most frequently listed by medical providers.
After examining and summarizing the different sources of HD triad
data, members of the study team participated in an iterative
triangulation exercise to create a conceptual schema that integrated
the patient, caregiver, and medical provider perspectives. The result
was a unified summary graphic (Figure 1) that represents each HD
triad domain in a user-friendly and pragmatic way.
Discussion
Findings from the expert surveys and individual phone-based
interviews with HD patients and caregivers offered perspectives on key
symptoms and issues most relevant to the HD triad. Although not
statistically tested because the number of patient–caregiver dyads was
insufficient, findings from the current study suggest that patients and
caregivers have different perceptions of the prevalence and importance
of various HD-related issues. The two cohorts discussed with varying
frequencies many HD-related issues. For example, patients spent more
time describing their problems with communication, memory, slower
processing, anxiety, and obsessions/compulsions. On the other hand,
caregivers spent more time describing problems in executive function-
ing, perseveration, disinhibition, and psychosis. These observed
differences are consistent with other qualitative research examining
the perspectives of similar patient populations with neurologic
conditions and caregivers across a broad spectrum of HRQOL
domains.19,25
It seems natural for patients to focus more on changes or
impediments to their communication abilities, as these are their direct
connections to the outside world. Even the slightest limitations in these
conduits can be perceived as both socially and emotionally devastating.
Patients are also likely more aware of deficits in their abilities to
remember events, and the longer time needed to process and encode
Figure 1. Huntington’s Disease Triad Conceptual Schema of Patient, Caregiver, and Provider Report. ADLs: Activities of daily living; IADLs:
Instrumental activities of daily living.
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information, as these are often perceptible manifestations that carry
significant functional, emotional, and social repercussions. Finally,
heightened awareness of anxiety (including obsessions/compulsions)
may be characteristic of the relatively earlier stage of the patient
sample, as anxiety is linked with feelings of helplessness, which is surely
amplified as one learns more about this disease and begins to observe
gradual declines in functioning across these domains.
Similarly, it is understandable that caregivers would spend relatively
greater amounts of time describing more observable and possibly more
severe problems related to an inability to follow instructions, make
decisions, and problem solve; or related to bizarre or psychotic
presentations. It is important to consider these possible differences in
perspective, especially when measuring outcomes related to HD triad
domains.
This study is not without limitations. Although efforts were taken to
enroll patients and caregivers from several regions across the United
States (thus attempting to ensure a more heterogeneous sample), the
study sample ultimately lacked racial–ethnic diversity. Future studies
that focus on African-American and Hispanic HD patient and
caregiver samples may provide additional information on the ways
race, ethnicity, and cultural group membership may affect symptom
sequelae. In addition, as purposive sampling was used through
established support groups, the patient participants described them-
selves as healthier and earlier in the disease process when compared
with caregiver participants. Subsequent studies would benefit from
enrollment of more late-stage patients.
In this study, the perspectives of patients, caregivers, and medical
providers were used to describe their personal experiences with
cognitive, emotional–behavioral, and motor symptoms and issues
related to HD. Using qualitative methods and analysis, we synthesized
these findings into a conceptual schema that expounds each major
concept of the HD triad to offer a better understanding of which
aspects are most common and/or most important to those affected.
This field may benefit from future mechanism of action research
studies that attempt to disentangle conceptually similar concepts (e.g.,
executive function and perseveration; impulsivity, and disinhibition)
and their unique relevance to HD triad–specific sequelae. Additional
studies designed to compare and contrast clinician and patient
concerns would also help to clarify potential disparities in patient–
physician communication (and its role on future treatment trial
selection) to ensure that treatments are ultimately best serving patients’
needs and interests. For example, in our study, under behavioral
concerns, ‘‘anger’’ was listed most frequently by clinician experts. The
most important behavioral symptoms for patients were ‘‘behavioral
problems’’ (which, in fact, may overlap with anger), and ‘‘stigma.’’
Similarly, in evaluation of motor concerns, ‘‘movements’’ were most
frequently noted by clinicians, but ‘‘falls,’’ ‘‘IADLs,’’ and ‘‘time
extension’’ were rated most important among patients.
These findings offer valuable information to HD researchers and
clinicians regarding the HD triad and its specific make up. The HD-
PRO-TRIADTM provides an advantage over more generic instruments
of HRQOL that do not fully capture the behavioral characteristics of
HD. In addition, to date, based on a thorough literature search, we have
found no other study that has focused specifically on cognitive, motor,
and emotional–behavioral issues from patients, ‘‘caregivers,’’ and medical
providers’ perspectives. Furthermore, the HD-PRO-TRIADTM does not
have some of the limitations of previous patient-reported outcome
measures developed for HD. The HD-QOL-I16 is available in French
and Italian, but not English. The HD-QoL14 did not assess accepted
norms for minimum sample patient sizes for the analyses it employed.26
This conceptual schema was used as the basis of a new patient-
reported outcome measure to assess the HD triad impact on
HRQOL — the HD-PRO-TRIADTM.17 This instrument may be
used to measure clinical or supportive care intervention to manage
disease and treatment-related burden in both clinical and research
settings.
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